Zoltán Garami
University of Debrecen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zoltán Garami.
Journal of Medical Case Reports | 2013
Csilla András; László Tóth; János Pósán; Emese Csiki; Miklós Tanyi; Zoltán Csiki; Zoltán Garami; Attila Enyedi; Tibor Flaskó; Zsolt Horváth
IntroductionSecondary bladder neoplasms are uncommon and they represent only 2% of all malignant bladder tumors.Case presentationThe authors present a case of a 59-year-old Caucasian man with a primary gastric adenocarcinoma that had been surgically removed 10 years before he developed bladder metastasis. He presented with low abdominal pain after 10 years without any symptoms. Cystoscopy and an abdominal computed tomography scan showed a bladder tumor. A transurethral resection of the bladder tumor was performed. A histological examination revealed an adenocarcinoma, which turned out to be a metastasis of the primary gastric tumor. One year later, abdominal surgery revealed peritoneal metastases.ConclusionThis is the first known case in Europe where bladder metastasis occurred 10 years after surgical removal of a primary gastric neoplasm. There are only four cases in the literature where metastases of the peritoneum developed 11 years after surgical removal of a primary gastric tumor.
Clinical and Experimental Medical Journal | 2010
Kornélia Lazányi; Peter Molnar; Antal Bugán; László Damjanovich; Zoltán Garami; Balázs Fülöp; Kornélia Szluha
Abstract The mental and emotional state of the individuals have a strong effect on the course of their illnesses as well as the speed of recovery. Adequate quantity and quality of information and social support are a prerequisite for mental, and often for physical well-being. In our investigation at the DE OEC, we gathered data on the psychological and physical states of 100 breast cancer patients in order to reveal the role of a helping atmosphere in the recovery phase of their illness. The results suggested that patients attending the HIVAS support group could cope with their disease and its side effects better, and experienced a higher level of well-being.
Familial Cancer | 2012
Miklós Tanyi; Judit Olasz; Janos L. Tanyi; László Tóth; Péter Antal-Szalmás; Tamás Bubán; Csilla András; Hilda Urbancsek; Zoltán Garami; Orsolya Csuka; László Damjanovich
Lynch syndrome (Hereditary nonpolyposis colorectal cancer, HNPCC) is an inherited disease with variable phenotype causing the development of colon cancer and other malignancies. The basis of the disease is believed to be the mismatch repair gene mutations. Genetic screening has been performed among the patients who have undergone surgery for colon cancer at the University of Debrecen, Department of Surgery. Tumor samples of the screened patients were submitted to immunohistochemistry on hMLH1, hMSH2 and hMSH6 genes, microsatellite instability testing, followed by sequencing and multiple ligation dependent probe amplification. Three families were identified with the missense mutation c.143A>C (p.Q48P) of hMLH1 gene. In one of the families a segregation analysis of this particular variant was also accomplished. The segregation analysis revealed a clear correlation between the tumor cases and the occurrence of this mutation. However, none of the analyzed 100 healthy controls demonstrated the same aberration. There is only one published evidence in the literature about the presence of this rare variant in any population. The Gln to Pro switch in the ATPase domain, a conservative region of the hMLH1 gene, creates significant changes in the protein structure. These results indicate that this mutation is the abnormality responsible for the patients’ phenotype and it is feasible that this particular aberration occurs more frequently among Hungarian Lynch syndrome patients.
Magyar sebészet | 2008
Zoltán Garami; Kornélia Szluha; Balázs Fülöp; Géza Lukács; László Damjanovich
Several predictors of local recurrence (LR) after breast conservation in early stage (stage I and II) breast cancer have been reported in the literature, but the importance of the individual factors does not appear to be clear. The presence of intraductal component (IC) is one of those factors; some authors regard it to be a predictor of LR, while others do not, or the latter have found a relationship with LR only if IC and certain other factors were present simultaneously. The authors investigated the impact of the presence of IC of various degrees on LR rate in various tumour sizes and degrees of histological anaplasia. Between 1996 and 2002, 701 patients with early stage breast cancer underwent breast conserving surgery. Based on the presence of IC, the tumours were divided into three groups: IC negative, MIC (IC < 25%) and EIC (IC > 25%). During the 65-month mean follow-up period, LR was discovered in 13.5% of the patients. Local recurrence in tumours without IC was found in 8.7% (recurrence rate: 0.017, 95% CI: 0.012-0.012). The relevant figures in MIC and EIC were 16.8% (recurrence rate 0.032, 95% CI: 0.021-0.047) and 25.6% (recurrence rate: 0.046, 95% CI: 0.033-0.064), respectively (p = 0.0001). If the size of the tumour was T1, the above figures were found to be 6.4%, 11% and 24.3%, while in size T2 tumours they were 11.5%, 22.9% and 27% (p < 0.005). If EIC was associated with G3 degree of differentiation, in IC-free tumours of size T1, the LR rate elevated from 6.1% to 31% (p = 0.008), while in size T2 the elevation was from 15.7% to 33.% (p = 0.02). Based on the above results, the authors concluded that the presence of the intraductal component predicts a greater risk to develop LR. This risk increases significantly if EIC is associated with G3 histological grade. Physicians must consider this fact in designing individually tailored adjuvant therapy for their patients. Special attention should also be paid to the follow-up of this group of patients.
Ejso | 2012
Zoltán Garami; Zsolt Hascsi; József Varga; T. Dinya; Miklós Tanyi; Ildikó Garai; László Damjanovich; László Galuska
Ejso | 2014
Miklós Tanyi; J. Olasz; Janos L. Tanyi; László Tóth; Péter Antal-Szalmás; Zsuzsa Ress; Tamás Bubán; Károly Palatka; Csilla András; Hilda Urbancsek; Zoltán Garami; Orsolya Csuka; László Damjanovich
Magyar onkologia | 2008
Kornélia Szluha; Kornélia Lazányi; Ákos Horváth; János Szántó; Judit Tóth; Zoltán Hernádi; Róbert Póka; László Damjanovich; Zoltán Garami; Balázs Fülöp; Peter Molnar
Magyar sebészet | 2006
Zoltán Garami; Benkó K; Kósa C; Balázs Fülöp; Géza Lukács
Magyar sebészet | 2012
Csaba Kósa; Zoltán Garami; Tamás Dinya; Balázs Fülöp
Archive | 2009
Zoltán Garami; Zsolt Hascsi; Ildikó Garai; Miklós Tanyi; Géza Lukács; László Damjanovich